A limited feasibility study presented at this year’s San Antonio Breast Cancer Symposium (SABCS) found that Seno Medical’s Imagio® Breast Imaging System using ...
A study presented at RSNA and published in Academic Radiology has found that Seno Medical’s Imagio® Breast Imaging System with opto-acoustic ultrasound (OA/US) imaging is more cost effective when ...
Seno Medical, a San Antonio, Texas firm, has won FDA approval to introduce its Imagio device that utilizes opto-acoustic imaging to help physicians identify whether breast lesions are benign or ...
CHICAGO, Nov. 28, 2017 /PRNewswire/ -- Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using optoacoustic (OA/US) imaging to differentiate ...
SAN ANTONIO, Dec. 11, 2018 /PRNewswire/ -- Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic (OA/US) imaging to differentiate ...
Seno Medical Instruments (San Antonio), a company developing opto-acoustic technology as a new tool for diagnosing breast cancer, has completed active enrollment of subjects in its U.S.-based PIONEER ...
Announcing a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2026.250312 .Bone mineral density (BMD) has long been the "gold ...
Bone mineral density (BMD) has long been the "gold standard" for assessing fracture risk. However, clinicians face a paradox when treating patients with Type 2 Diabetes Mellitus (T2DM). Many patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results